DEFERRED GRANT INCOME

3 Months Ended

Mar. 31, 2019

Deferred Grant Income [Abstract]

Deferred Grant Income [Text Block]

NOTE 7 - DEFERRED GRANT INCOME

In July 2017 the Company received an award in the amount of $15,912 from CIRM to aid in funding the Company’s Phase 3 study of NurOwn®, for the treatment of ALS. An aggregate amount of $12,550 and $9,050 related to the project was received through March 31, 2019 and December 31, 2018, respectively. The award does not bear a royalty payment commitment nor is the award otherwise refundable. $1,347 and $6,267 was recorded as participation by CIRM in research and development expenses during the three months ended in March 31, 2019 and during the year ended December 31, 2018, respectively.